A Phase 1 Dose Escalation Study of Milademetan in Combination with 5-Azacitidine (AZA) in Patients with Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
- Resource Type
- Abstract
- Source
- In
Blood 13 November 2019 134 Supplement 1:3932-3932 - Subject
- Language
- ISSN
- 0006-4971